Populations A, B and C were next sorted from PBMC of CLL patients (n= 3) based on their pattern of expression of ROR-1, CD5, CD20, CD19 and CD79b and their IGHV clonality was assessed by HCDR3 length spectra-typing. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.